Potassium Phosphate, Unspecified Form
drug drugOn this page
Also known as Kali phosphoricumKalium phosphoricumPotassium (as phosphate)Potassium phosphateunspecified form
Summary
Potassium Phosphate, Unspecified Form (CHEMBL4298074) is a phase-3 clinical-stage unknown; indicated across 1 condition including hypoglycemia.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 1 condition
- Clinical trials: 2
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL4298074 |
| Name | Potassium Phosphate, Unspecified Form |
| Type | Unknown |
| Max phase | 3 |
Also known as: Kali phosphoricum, Kalium phosphoricum, Potassium (as phosphate), Potassium phosphate, unspecified form, POTASSIUM PHOSPHATE, UNSPECIFIED FORM
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
Clinical trials
Total trials: 2.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE3 | 1 |
| EARLY_PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00004284 | PHASE3 | COMPLETED | Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria |
| NCT02866435 | EARLY_PHASE1 | COMPLETED | Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.